Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
432 people get BGMD articles and Market Currents by email alert.
Get email alerts on BGMD »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
GlobeNewswire (May 10, 2013)
-
GlobeNewswire (May 9, 2013)
-
GlobeNewswire (May 9, 2013)
-
GlobeNewswire (May 8, 2013)
-
GlobeNewswire (May 2, 2013)
-
GlobeNewswire (Apr 10, 2013)
-
GlobeNewswire (Mar 13, 2013)
-
GlobeNewswire (Feb 27, 2013)
-
-
-
GlobeNewswire (Jan 30, 2013)
-
GlobeNewswire (Jan 25, 2013)
-
GlobeNewswire (Jan 24, 2013)
-
GlobeNewswire (Jan 24, 2013)
To learn more about Seeking Alpha Pro, click here.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
20 Micro-Cap Stocks Being Snapped Up By Hedge FundsKapitall • Thu, Dec 15, 2011
-
Biotech IPO Class of 2011 Takes DrubbingThe Burrill Report • Sun, Aug 14, 2011 -
-
GlobeNewswire (May 10, 2013)
-
GlobeNewswire (May 9, 2013)
-
GlobeNewswire (May 9, 2013)
-
GlobeNewswire (May 8, 2013)
-
GlobeNewswire (May 2, 2013)
-
GlobeNewswire (Apr 10, 2013)
-
GlobeNewswire (Mar 13, 2013)
-
GlobeNewswire (Feb 27, 2013)
-
GlobeNewswire (Jan 30, 2013)
-
GlobeNewswire (Jan 25, 2013)
-
GlobeNewswire (Jan 24, 2013)
-
GlobeNewswire (Jan 24, 2013)
-
GlobeNewswire (Jan 2, 2013)
-
GlobeNewswire (Dec 11, 2012)
-
GlobeNewswire (Nov 20, 2012)
-
GlobeNewswire (Nov 13, 2012)
-
GlobeNewswire (Nov 13, 2012)
BGMD vs. ETF Alternatives
Company Description
Currently, there's no company description for BGMD.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Wednesday, April 10, 10:31 AM BG Medicine (BGMD +3.6%) trades up after announcing earlier that partner Abbott (ABT +0.2%) has obtained a CE Mark for its Galectin-3 assay run on the Architect immunochemistry platform. The Galectin-3 assay is an indicator that assesses the risk for readmission in heart failure. BGMD is partnering with four diagnostic instrument manufacturers to commercialize automated versions of the test, making it available in several European countries, pending country registration. Comment! [Healthcare, On the Move, Global & FX]
- Wednesday, March 13, 10:19 AM BG Medicine (BGMD +14%) ramps higher after beating Q4 EPS estimates on a narrower-than-expected loss. Revenue jumped nearly 250% Y/Y, driven largely by increased sales of its BGM Galectin-3(R) test, with product margins increasing 10% over the same period from 60% to 70%. Net losses also decreased by 38% Y/Y from $4.7M to $2.9M, primarily from an adjustment of accrued R&D expenses. Comment! [Healthcare, Earnings, On the Move]
-
Wednesday, March 13, 9:10 AM
Premarket gainers: BGMD +15%. SUMR +10%. PPHM +5%.
Losers: SPPI -36%. VELT -32%. ASMI -13%. EXPR -13%. TEU -10%. DOLE -7%. WFR -6%. Comment! [On the Move] - Wednesday, February 27, 10:39 AM BG Medicine (BGMD +11%) ramps higher this morning after announcing the publication of two studies demonstrating the benefit of repeated galectin-3 testing as a tool in the assessment of patients with heart failure. The studies demonstrate that periodic evaluation of galectin-3 levels can help clinicians identify those at greater risk of unplanned hospital admission and cardiovascular morbidity and mortality. Comment! [Healthcare, On the Move]
-
Friday, January 25, 12:45 PM
Midday top 10 gainers: EFII +15%. OSK +15%. SHIP +15%. SYNA +15%. LSCC +14%. NFLX +14%. QLGC +13%. BDR +13%. CIMT +13%. CRUS +12%.
Midday top 10 Losers: NFBK -27%. ZN -26%. SCSS -18%. SCSC -15%. BGMD -15%. CTRP -13%. HTCH -11%. EGHT -10%. ARWR -8%. MSL -7%. Comment! [On the Move] -
Friday, January 25, 9:10 AM
Premarket gainers: INFA +10%. TPX +10%. ECTE +9%. OSK +8%. STP +6%. THLD +7%. SNE +6%.
Losers: SCSS -15%. BGMD -15%. EGHT -10%. SFL -8%.
1 Comment [On the Move] - Friday, January 25, 8:02 AM BG Medicine (BGMD) -10% premarket after announcing a secondary to price this morning and its intention to purchase up to $12M of its stock from a big holder, Aspire Capital. Comment! [Healthcare, On the Move]
-
Thursday, January 3, 12:45 PM
Midday top 10 gainers: SPWR +38%. VISN +30%. MDCI +20%. FORD +20%. BGMD +19%. TSL +19%. CRDC +19%. FOLD +19%. TELK +18%. JASO +16%.
Midday top 10 Losers: LPH -73%. ALLT -23%. MLNX -14%. FDO -12%. AMPL -12%. TRIT -11%. PKT -10%. SSI -9%. LODE -9%. HPJ -9%. 1 Comment [On the Move] -
Thursday, January 3, 9:10 AM
Premarket gainers: BGMD +22%. SPWR +16%. ALU +10%. CBMX +10%. FOLD +8%. TASR +6%. LDK +6%. ZGNX +5%.
Losers: MLNX -18%. ALLT -10%. FDO -10%. KERX -6%. BIIB -6%. Comment! [On the Move] - Thursday, January 3, 8:28 AM BG Medicine (BGMD) rockets 24% after saying it has received the EU's CE mark for the first automated version of the company's Galectin-3 blood test for improving the management of heart conditions. BG is working with four partners to commercialize the test, including Abbott Labs (ABT) and Siemens (SI). The EU approval comes just a week after SA author Robert Fabian called BG Medicine a "hidden gem." (PR) Comment! [Healthcare, On the Move]
-
Wednesday, January 2, 5:37 PM
After-hours top gainers, as of 5:15 p.m.: BGMD +14%. KYAK +8%. SZYM +6%. LNDC +4%. NAVB +3%.
After-hours top losers: MLNX -16%. RMBS -12%. ESIO -8%. AUO -6%. OME -4%. 1 Comment [On the Move] -
Wednesday, December 12, 2012, 9:10 AM
Premarket gainers: YMI +79%. DSTI +15%. SCMP +11%. ACAD +9%. BGMD +10%.
Losers: RSOL -16%. CIE -11%. MCP -6%. Comment! [On the Move] -
Tuesday, December 11, 2012, 6:10 PM
After-hours top gainers, as of 5:15 p.m.: RTEC +8%. DLB +6%. MCBC +4%. BGMD +4%. GEO +3%.
After-hours top losers: GEOS -12%. CIE -10%. EXAR -7%. NTSP -7%. ALXA -7%. 1 Comment [On the Move] -
Tuesday, December 11, 2012, 12:45 PM
Midday top 10 gainers: BGMD +146%. SOMX +75%. ACUR +56%. TNS +43%. ULBI +18%. MEAD +16%. ESYS +15%. SZYM +14%. GTXI +13%. CLWR +12%.
Midday top 10 Losers: CBMX -11%. ESIO -11%. AMCN -9%. SEV -9%. GGAL -8%. SPW -8%. TELK -7%. [[JW-A]] -7%. MGLN -7%. SXC -7%. 2 Comments [On the Move] - Tuesday, December 11, 2012, 10:31 AM BG Medicine (BGMD +78%) nearly doubles in value today after the company says it's CardioSCORE test has been awarded a CE Mark enabling it for commercial sale in the EU and other countries that recognize the CE Mark. The CardioSCORE is a patented diagnostic blood test designed to improve risk prediction of major cardiovascular events. The test isn't yet available in the U.S., however the company is currently in discussions with the FDA to obtain 510(k) clearance. Comment! [Healthcare, On the Move, Global & FX]
-
Friday, November 23, 2012, 12:45 PM
Midday top 10 gainers: CCCL +42%. MAPP +21%. BGMD +21%. MCP +18%. INUV +16%. FIZZ +15%. ROSG +14%. DAC +13%. RIMM +13%. RIC +12%.
Top 10 Losers: KITD -64%. PTGI -17%. SGOC -12%. HDSN -9%. TELK -9%. SAB -8%. HRT -8%. NFEC -8%. THQI -7%. RCON -7%. 1 Comment [On the Move]
-
- View all 0 replies
-
Ryan Mallory
Fuinhaz Setups for March 13 2013 | $ASML $BGMD $GLUU $HTWR $NPSH $PERI $YNDX http://stks.co/r5Ej - View all 0 replies
-
Ryan Mallory
Mid-Day Charts & Technical Analysis: $SHLD, $VHC, $BGMD & Others | http://bit.ly/Z0tCiZ - View all 0 replies
-
- View all 2 replies
-
sheldond: That was a pretty prescient call. Too bad I didn't put more on this oppotunity. Good Call! -
Scott Matusow: Thanks Sheldon --we all need more of these! Now I have to make sure I don't make bad calls, u know like the election prediction I made! lol!
-
- View all 0 replies
-
Scott Matusow
$LGND $19.05 alerted at $16.60 $BGMD $1.35 alerted at $1.05 $AVEO $6.80 alerted at $6.60 $FOLD $4.85 alerted at $4.35 - View all 4 replies
-
-
Scott Matusow: blak, u must lose money in the market -- I also gave a price target of $2.25 after financing -- that's on traders, now learn to make money
-
Scott Matusow
I bought some $BGMD undervalued play PT opinion is $1.45 - $1.55 short term expect coverage soon and others :) - View all 3 replies
-
-
-
Scott Matusow
I bought some $BGMD for a bounce - undervalued play PT opinion is $1.45 - $1.55 short term - View all 0 replies
-
Jim Van Meerten
BGMD - 48% Barchart technical sell signal - lost 15.57% in the last month - Relative Strength Index 37.98% - View all 0 replies
-
Jim Van Meerten
BGMD - 80% Barchart short tem, buy signal - 15 new highs and up 74.36% in the last month - Relative Strength Index 72.09% - View all 0 replies
LATEST REPLIES
-
Scott Matusow
$LGND $19.05 alerted at $16.60 $BGMD $1.35 alerted at $1.05 $AVEO $6.80 alerted at $6.60 $FOLD $4.85 alerted at $4.35 - View all 4 replies
-
-
Scott Matusow: blak, u must lose money in the market -- I also gave a price target of $2.25 after financing -- that's on traders, now learn to make money
-
- View all 2 replies
-
sheldond: That was a pretty prescient call. Too bad I didn't put more on this oppotunity. Good Call!
-
Scott Matusow: Thanks Sheldon --we all need more of these! Now I have to make sure I don't make bad calls, u know like the election prediction I made! lol!
-
Scott Matusow
I bought some $BGMD undervalued play PT opinion is $1.45 - $1.55 short term expect coverage soon and others :) - View all 3 replies
-
-